Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/31/1997 | WO1997041226A3 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor |
12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
12/31/1997 | WO1997030159A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
12/31/1997 | CN1169161A Attenuated viruses and method of making same |
12/31/1997 | CN1169160A Deoxyribonucleic acid coding for glutathion-S-transferase and its use |
12/31/1997 | CN1169159A Method of desulfurization of fossil fuel with flavoprotein |
12/31/1997 | CN1169158A Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
12/31/1997 | CN1168922A Process for production of secretory kexz derivatives |
12/31/1997 | CN1036850C Novel cell cortex protein |
12/31/1997 | CA2261029A1 Aatt promoter element and transcription factor |
12/31/1997 | CA2259636A1 Process for extracting and purifying recombinant, non-lipidised osp-protein |
12/31/1997 | CA2259459A1 Method for preparing assay supports having an ordered set of reaction zones |
12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
12/31/1997 | CA2259125A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
12/31/1997 | CA2259124A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
12/31/1997 | CA2258961A1 A cell-free system for initiation of dna replication |
12/31/1997 | CA2258941A1 Broad specificity affinity arrays: a qualitative approach to complex sample discrimination |
12/31/1997 | CA2258936A1 Method for producing hybridisation complexes whose stability is substantially independent of the base composition of two hybridised nucleic acid molecules |
12/31/1997 | CA2258576A1 Gene conferring disease resistance in plants and uses thereof |
12/31/1997 | CA2258564A1 Brain glycogen phosphorylase cancer antigen |
12/31/1997 | CA2258496A1 Anti-cocaine catalytic antibody |
12/31/1997 | CA2258265A1 Disease resistance in vitis |
12/31/1997 | CA2258168A1 Recombinant vaccine for diseases caused by encapsulated organisms |
12/31/1997 | CA2257905A1 Genetic control of flowering |
12/31/1997 | CA2257849A1 Glucuronide repressors and uses thereof |
12/31/1997 | CA2257832A1 Ozone-induced gene expression in plants |
12/31/1997 | CA2257180A1 Method of identifying cytochrome p450 |
12/31/1997 | CA2256501A1 Plant gene for p-hydroxyphenylpyruvate dioxygenase |
12/31/1997 | CA2255057A1 Gene expression in plants |
12/31/1997 | CA2250830A1 Chromosomal rearrangement by insertion of two recombination substrates |
12/31/1997 | CA2230088A1 A novel hypertension related calcium regulated gene (hcarg) |
12/30/1997 | US5703220 May be used to provide therapeutic vehicles for treatment of processes involving function of melanocortin receptors |
12/30/1997 | US5703217 Nucleotide fragment of the 23S ribosomal RNA of mycobacteria, derived probes and primers, reagent and detection method |
12/30/1997 | US5703213 Monoclonal antibodies which recognize an adenocarcinoma cell antigen |
12/30/1997 | US5703209 Purified and isolated polypeptide encoded by nucleic acid sequence of nucleic acid molecule which is fragment of gene encoding amyloid precursor protein isoform |
12/30/1997 | US5703206 Macrophage inflammatory protein 2 (MIP-2) |
12/30/1997 | US5703057 Expression library immunization |
12/30/1997 | US5703055 Generation of antibodies through lipid mediated DNA delivery |
12/30/1997 | US5703054 Oligonucleotide modulation of protein kinase C |
12/30/1997 | US5703049 High methionine derivatives of α-hordothionin for pathogen-control |
12/30/1997 | US5703048 Hepatocyte growth factor |
12/30/1997 | US5703044 Plant protein |
12/30/1997 | US5703043 Bone morphogenetic protein-10 (BMP-10) compositions |
12/30/1997 | US5703039 Chimeric toxins |
12/30/1997 | US5703038 Emhanced biological activity |
12/30/1997 | US5702946 Interleukins |
12/30/1997 | US5702938 Human tissue plasminogen activator |
12/30/1997 | US5702936 Polypeptides |
12/30/1997 | US5702934 Processes for producing an enzyme |
12/30/1997 | US5702933 Control of fruit ripening and senescence in plants |
12/30/1997 | US5702931 Mutagenic oligonucleotide introduces desired mutation at one site, and at a second site, introduces or eliminates a restriction site, allowing one to screen for desired mutation by restriction analysis |
12/30/1997 | US5702926 Useful in strand displacement amplification |
12/30/1997 | US5702925 Nucleoside analogue method |
12/30/1997 | US5702921 Expression of biologically active human C-reactive protein in escherichia coli |
12/30/1997 | US5702920 Polypeptides |
12/30/1997 | US5702919 DNA encoding canine granulocyte macrophage colony stimulating factor |
12/30/1997 | US5702917 Polynucleotides encoding human ICAM-4 |
12/30/1997 | US5702916 Biological Containment |
12/30/1997 | US5702914 Genetic engineering; bioassay |
12/30/1997 | US5702907 Nucleotide sequence |
12/30/1997 | US5702905 Specificity, sensitivity; diagnosis of cardiac muscle damage |
12/30/1997 | US5702904 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
12/30/1997 | US5702903 Detecting gene that has been amplified or detecting increased expression of gene products |
12/30/1997 | US5702902 Using gene transcript |
12/30/1997 | US5702898 Procedure for normalization of cDNA libraries |
12/30/1997 | US5702894 Methods of analysis and manipulating of DNA utilizing mismatch repair systems |
12/30/1997 | US5702892 Phage-display of immunoglobulin heavy chain libraries |
12/30/1997 | US5702891 HAV probes for use in solution phase sandwich hybridization and assays for detecting the presence of HAV |
12/30/1997 | US5702886 Chromosome I8Q loss and prognosis in colorectal cancer |
12/30/1997 | US5702884 For selective separation of leucocytes from erythrocytes |
12/30/1997 | US5702883 Methods for detection of mutagens using luminescence gene |
12/30/1997 | US5702705 Antibody methods for the treatment of a hormone-mediated disease |
12/30/1997 | US5702698 Promoting production of colony stimulating factor |
12/30/1997 | US5702384 Apparatus for gene therapy |
12/30/1997 | CA2133850C Process for preparing virus-resistant transgenic plant |
12/30/1997 | CA1339606C Polypeptides complementary to peptides or proteins having an amino acid sequence or necleotide coding sequence at least partially known |
12/29/1997 | EP0814166A2 Methods and compositions for the production of stably transformed fertile monocot plants and cells thereof |
12/29/1997 | EP0814165A2 Method for constructing transformed yeast cells, that do not contain a selective marker gene |
12/29/1997 | EP0814164A2 A novel cDNA of direct-acting fibrinolytic serine protease |
12/29/1997 | EP0814162A2 Expression of the alpha-toxin gene (hla) of staphylococcus aureus using a chromosomally encoded hla-lacZ gene fusion |
12/29/1997 | EP0814161A1 Genetic control of polar auxin transport in plants and manipulation of plant growth, architecture and morphogenesis |
12/29/1997 | EP0814160A2 KEX2 proteinase inhibitor |
12/29/1997 | EP0814159A2 Transgenic non-human animals capable of producing heterologous antibodies |
12/29/1997 | EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics |
12/29/1997 | EP0814157A2 Diagnostic marker for variants of presenilin genes associated with Alzheimers Disease and Familial Adult Onset Alzheimers Disease |
12/29/1997 | EP0814156A2 Method for the purification of DNA |
12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
12/29/1997 | EP0814089A2 Respiratory syncytial virus: vaccines and diagnostic assays |
12/29/1997 | EP0813682A1 Multiple drug resistance gene of aspergillus fumigatus |
12/29/1997 | EP0813609A1 Method of nucleic acid analysis |
12/29/1997 | EP0813606A2 Method of purification of recombinant viral vectors containing a therapeutic gene |
12/29/1997 | EP0813605A1 Modified starch from plants, plants synthesizing this starch, and process for its preparation |
12/29/1997 | EP0813604A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand |
12/29/1997 | EP0813603A1 Expression of gene products from genetically manipulated strains of bordetella |
12/29/1997 | EP0813602A1 Herbicide resistant plants |
12/29/1997 | EP0813601A2 Proteinase k variants having decreased adsorption and increased hydrolysis |
12/29/1997 | EP0813600A2 Enzymatic process for producing gdp-alpha-d-mannose, a gdp mannose pyrophosphorylase and phosphomannomutase suitable for that process, the extraction of the said enzymes, and an enzyme test |
12/29/1997 | EP0813599A1 Plant adenylosuccinate synthetase and dna coding therefor |
12/29/1997 | EP0813596A2 Subtilisin carlsberg variants having decreased adsorption and increased hydrolysis |
12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |